Search

Clear all

Refine your search

Tags
Territory
Jurisdiction
Language

892 results found

Article

Borden Ladner Gervais LLP | Canada | 26 Apr 2021

La propriété intellectuelle et votre entreprise : ce que vous devez savoir

La propriété intellectuelle (PI) peut revêtir plusieurs formes, notamment les marques de commerce, les droits d’auteur, les dessins industriels, les…
Article

Borden Ladner Gervais LLP | Canada | 26 Apr 2021

Intellectual property and your business: What you need to know

Intellectual Property (IP) comes in many forms, including trademarks, copyrights, industrial designs, trade secrets, plant breeders rights, and…
Article

Borden Ladner Gervais LLP | Canada | 16 Apr 2021

Federal Court of Appeal interprets CSP regulations and denies patent term restoration

In a recent case, the Federal Court of Appeal (FCA/the Court) overturned a decision of the Federal Court (FC) and held that that the Minister of…
Article

Borden Ladner Gervais LLP | Canada | 15 Mar 2021

FCA provides much needed clarification on obviousness and anticipation

In Apotex v. Shire, the Federal Court of Appeal (FCA) dismissed Apotex' appeal and affirmed the decision of the Trial Judge holding that the patent…
Article

Borden Ladner Gervais LLP | Canada | 15 Mar 2021

Ontario Superior Court dismisses Apotex’s claims for damages under Statutes of Monopolies

In March 2021, the Ontario Superior Court granted summary judgment, in favour of Lilly, dismissing Apotex’s claim for treble damages pursuant to the…
Article

Borden Ladner Gervais LLP | Canada | 16 Dec 2020

Pharmaceutical and Biotechnology Litigation in the Federal Court of Canada

Canada has a linkage system similar to the Hatch-Waxman system in the United States. This system is governed by the Patented Medicines (Notice of…
Article

Borden Ladner Gervais LLP | Canada | 9 Dec 2020

Federal Court of Appeal clarifies standard for granting leave in NOC cases

When the Patented Medicines (Notice of Compliance) Regulations (the NOC Regulations) were amended in 2017, the procedure governing their proceedings…
Article

Borden Ladner Gervais LLP | Canada | 30 Jun 2020

Parts of amended Patented Medicines Regulations related to the PMPRB struck down

On June 29, 2020, the Federal Court issued its decision in the judicial review of recent Amendments to the Patented Medicines Regulations. These…
Article

Borden Ladner Gervais LLP | Canada | 26 Mar 2020

COVID-19 Emergency Response Act and IP Rights

The COVID-19 Emergency Response Act received royal assent in Canada on March 25, 2020. It contains amendments to both the Patent Act and the Food and…
Article

Borden Ladner Gervais LLP | Canada | 18 Nov 2019

Expanding Protection of IP Licensees: Changes to the BIA and CCAA via the Budget Implementation Act, 2018, No. 2

​On November 1, 2019, amendments to the Bankruptcy and Insolvency Act, R.S.C. 1985, c. B-3 (BIA) and the Companies' Creditors Arrangement Act, R.S.C…
Previous page 1 2 3 ...